Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Big Multiple Sclerosis Data network: an international registry research network

A. Glaser, H. Butzkueven, A. van der Walt, O. Gray, T. Spelman, C. Zhu, M. Trojano, P. Iaffaldano, MA. Battaglia, G. Lucisano, S. Vukusic, I. Vukusic, R. Casey, D. Horakova, J. Drahota, M. Magyari, H. Joensen, L. Pontieri, F. Elberling, P. Klyve,...

. 2024 ; 271 (6) : 3616-3624. [pub] 20240401

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013724
E-zdroje Online Plný text

NLK ProQuest Central od 1997-04-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-04-01 do Před 1 rokem

BACKGROUND: The Big Multiple Sclerosis Data (BMSD) network ( https://bigmsdata.org ) was initiated in 2014 and includes the national multiple sclerosis (MS) registries of the Czech Republic, Denmark, France, Italy, and Sweden as well as the international MSBase registry. BMSD has addressed the ethical, legal, technical, and governance-related challenges for data sharing and so far, published three scientific papers on pooled datasets as proof of concept for its collaborative design. DATA COLLECTION: Although BMSD registries operate independently on different platforms, similarities in variables, definitions and data structure allow joint analysis of data. Certain coordinated modifications in how the registries collect adverse event data have been implemented after BMSD consensus decisions, showing the ability to develop together. DATA MANAGEMENT: Scientific projects can be proposed by external sponsors via the coordinating centre and each registry decides independently on participation, respecting its governance structure. Research datasets are established in a project-to-project fashion and a project-specific data model is developed, based on a unifying core data model. To overcome challenges in data sharing, BMSD has developed procedures for federated data analysis. FUTURE PERSPECTIVES: Presently, BMSD is seeking a qualification opinion from the European Medicines Agency (EMA) to conduct post-authorization safety studies (PASS) and aims to pursue a qualification opinion also for post-authorization effectiveness studies (PAES). BMSD aspires to promote the advancement of real-world evidence research in the MS field.

Center for Outcomes Research and Clinical Epidemiology CORESEARCH Pescara Italy

Department of Clinical Neuroscience Karolinska Institute Stockholm Sweden

Department of Life Sciences University of Siena Siena Italy

Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Department of Neurology Danish Multiple Sclerosis Center Copenhagen University Hospital Rigshospitalet 2100 Copenhagen Denmark

Department of Neurology The Alfred Hospital Melbourne VIC Australia

Department of Neuroscience Central Clinical School Monash University Melbourne VIC Australia

Department of Translational Biomedicine and Neurosciences DiBraiN University of Bari Aldo Moro Bari Italy

Eugène Devic EDMUS Foundation Against Multiple Sclerosis State Approved Foundation 69677 Bron France

IMPULS Endowment Fund Prague Czech Republic

INSERM 1028 et CNRS UMR 5292 Observatoire Français de la Sclérose en Plaques Centre de Recherche en Neurosciences de Lyon 69003 Lyon France

Research Department Italian Multiple Sclerosis Foundation Genoa Italy

School of Medicine University Aldo Moro Bari Italy

Service de Neurologie sclérose en plaques pathologies de la myéline et neuro inflammation Hospices Civils de Lyon Hôpital Neurologique Pierre Wertheimer 69677 Bron France

South Eastern Health and Social Care Trust Belfast UK

The Danish Multiple Sclerosis Registry Copenhagen University Hospital Rigshospitalet Copenhagen Denmark

Université de Lyon Université Claude Bernard Lyon 1 69000 Lyon France

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013724
003      
CZ-PrNML
005      
20240905133450.0
007      
ta
008      
240725s2024 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00415-024-12303-6 $2 doi
035    __
$a (PubMed)38561543
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Glaser, Anna $u Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
245    10
$a Big Multiple Sclerosis Data network: an international registry research network / $c A. Glaser, H. Butzkueven, A. van der Walt, O. Gray, T. Spelman, C. Zhu, M. Trojano, P. Iaffaldano, MA. Battaglia, G. Lucisano, S. Vukusic, I. Vukusic, R. Casey, D. Horakova, J. Drahota, M. Magyari, H. Joensen, L. Pontieri, F. Elberling, P. Klyve, EF. Mouresan, L. Forsberg, J. Hillert
520    9_
$a BACKGROUND: The Big Multiple Sclerosis Data (BMSD) network ( https://bigmsdata.org ) was initiated in 2014 and includes the national multiple sclerosis (MS) registries of the Czech Republic, Denmark, France, Italy, and Sweden as well as the international MSBase registry. BMSD has addressed the ethical, legal, technical, and governance-related challenges for data sharing and so far, published three scientific papers on pooled datasets as proof of concept for its collaborative design. DATA COLLECTION: Although BMSD registries operate independently on different platforms, similarities in variables, definitions and data structure allow joint analysis of data. Certain coordinated modifications in how the registries collect adverse event data have been implemented after BMSD consensus decisions, showing the ability to develop together. DATA MANAGEMENT: Scientific projects can be proposed by external sponsors via the coordinating centre and each registry decides independently on participation, respecting its governance structure. Research datasets are established in a project-to-project fashion and a project-specific data model is developed, based on a unifying core data model. To overcome challenges in data sharing, BMSD has developed procedures for federated data analysis. FUTURE PERSPECTIVES: Presently, BMSD is seeking a qualification opinion from the European Medicines Agency (EMA) to conduct post-authorization safety studies (PASS) and aims to pursue a qualification opinion also for post-authorization effectiveness studies (PAES). BMSD aspires to promote the advancement of real-world evidence research in the MS field.
650    _2
$a lidé $7 D006801
650    _2
$a big data $7 D000077558
650    _2
$a šíření informací $7 D033181
650    _2
$a mezinárodní spolupráce $7 D007391
650    12
$a roztroušená skleróza $x epidemiologie $x terapie $7 D009103
650    12
$a registrace $7 D012042
655    _2
$a časopisecké články $7 D016428
700    1_
$a Butzkueven, Helmut $u Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia
700    1_
$a van der Walt, Anneke $u Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia
700    1_
$a Gray, Orla $u South Eastern Health and Social Care Trust, Belfast, UK
700    1_
$a Spelman, Tim $u Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden $u Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia
700    1_
$a Zhu, Chao $u Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia
700    1_
$a Trojano, Maria $u School of Medicine, University "Aldo Moro", Bari, Italy
700    1_
$a Iaffaldano, Pietro $u Department of Translational Biomedicine and Neurosciences, DiBraiN University of Bari Aldo Moro, Bari, Italy
700    1_
$a Battaglia, Mario A $u Research Department, Italian Multiple Sclerosis Foundation, Genoa, Italy $u Department of Life Sciences, University of Siena, Siena, Italy
700    1_
$a Lucisano, Giuseppe $u Department of Translational Biomedicine and Neurosciences, DiBraiN University of Bari Aldo Moro, Bari, Italy $u Center for Outcomes Research and Clinical Epidemiology-CORESEARCH, Pescara, Italy
700    1_
$a Vukusic, Sandra $u Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, 69677, Bron, France $u INSERM 1028 et CNRS UMR 5292, Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, 69003, Lyon, France $u Université de Lyon, Université Claude Bernard Lyon 1, 69000, Lyon, France $u Eugène Devic EDMUS Foundation Against Multiple Sclerosis, State-Approved Foundation, 69677, Bron, France
700    1_
$a Vukusic, Irena $u Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, 69677, Bron, France $u INSERM 1028 et CNRS UMR 5292, Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, 69003, Lyon, France $u Université de Lyon, Université Claude Bernard Lyon 1, 69000, Lyon, France $u Eugène Devic EDMUS Foundation Against Multiple Sclerosis, State-Approved Foundation, 69677, Bron, France
700    1_
$a Casey, Romain $u Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, 69677, Bron, France $u INSERM 1028 et CNRS UMR 5292, Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, 69003, Lyon, France $u Université de Lyon, Université Claude Bernard Lyon 1, 69000, Lyon, France $u Eugène Devic EDMUS Foundation Against Multiple Sclerosis, State-Approved Foundation, 69677, Bron, France
700    1_
$a Horakova, Dana $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Drahota, Jiri $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine Charles University and General University Hospital in Prague, Prague, Czech Republic $u IMPULS Endowment Fund, Prague, Czech Republic
700    1_
$a Magyari, Melinda $u Department of Neurology, Danish Multiple Sclerosis Center, Copenhagen University Hospital Rigshospitalet, 2100, Copenhagen, Denmark
700    1_
$a Joensen, Hanna $u The Danish Multiple Sclerosis Registry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
700    1_
$a Pontieri, Luigi $u The Danish Multiple Sclerosis Registry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
700    1_
$a Elberling, Frederik $u The Danish Multiple Sclerosis Registry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
700    1_
$a Klyve, Pernilla $u Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
700    1_
$a Mouresan, Elena Flavia $u Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
700    1_
$a Forsberg, Lars $u Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
700    1_
$a Hillert, Jan $u Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. jan.hillert@ki.se $1 https://orcid.org/0000000273866732
773    0_
$w MED00002835 $t Journal of neurology $x 1432-1459 $g Roč. 271, č. 6 (2024), s. 3616-3624
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38561543 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133444 $b ABA008
999    __
$a ok $b bmc $g 2143491 $s 1225590
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 271 $c 6 $d 3616-3624 $e 20240401 $i 1432-1459 $m Journal of neurology $n J Neurol $x MED00002835
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...